Cargando…

Selective Expansion of NKG2C+ Adaptive NK Cells Using K562 Cells Expressing HLA-E

Adaptive natural killer (NK) cells expressing self-specific inhibitory killer-cell immunoglobulin-like receptors (KIRs) can be expanded in vivo in response to human cytomegalovirus (HCMV) infection. Developing a method to preferentially expand this subset is essential for effective targeting of allo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phan, Minh-Trang Thi, Kim, Jinho, Koh, Seung Kwon, Lim, Yuree, Yu, Hongbi, Lee, Mijeong, Lee, Jong-Min, Kang, Eun-Suk, Kim, Hyun-Young, Kim, Sang-Ki, Hwang, Ilwoong, Cho, Duck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409060/ https://www.ncbi.nlm.nih.gov/pubmed/36012691 http://dx.doi.org/10.3390/ijms23169426

Ejemplares similares

Comparison of the different anti-CD16 antibody clones in the activation and expansion of peripheral blood NK cells
por: Kim, Jinho, et al.
Publicado: (2023)

Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21
por: Kweon, SoonHo, et al.
Publicado: (2019)

Natural Killer Cell Expansion and Cytotoxicity Differ Depending on the Culture Medium Used
por: Koh, Seung Kwon, et al.
Publicado: (2022)

A Flow Cytometry-Based Whole Blood Natural Killer Cell Cytotoxicity Assay Using Overnight Cytokine Activation
por: Kim, Jinho, et al.
Publicado: (2020)

Phenotypic and Functional Analysis of Human NK Cell Subpopulations According to the Expression of FcεRIγ and NKG2C
por: Kim, Kyung Hwan, et al.
Publicado: (2019)

The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells
por: Kaulfuss, Meike, et al.
Publicado: (2023)

Upregulation of Myc promotes the evasion of NK cell-mediated immunity through suppression of NKG2D ligands in K562 cells
por: Lee, Young-Shin, et al.
Publicado: (2019)

Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
por: Béziat, Vivien, et al.
Publicado: (2015)

Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of “senescent” NK cells to lose CD57 expression and start expressing NKG2A
por: Streltsova, Maria A., et al.
Publicado: (2018)

Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors
por: Koch, Christine, et al.
Publicado: (2017)

Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
por: Fisher, Jack G., et al.
Publicado: (2022)

Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease
por: Huergo-Zapico, Leticia, et al.
Publicado: (2014)

S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY
por: Encinas, Jessica, et al.
Publicado: (2023)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
por: Murad, Shafiq, et al.
Publicado: (2022)

Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
por: Thompson, Thornton W, et al.
Publicado: (2017)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
por: Huisman, Brooke D., et al.
Publicado: (2023)

Potential of the NKG2D/NKG2DL Axis in NK Cell-Mediated Clearance of the HIV-1 Reservoir
por: Desimio, Maria G., et al.
Publicado: (2019)

Manufacturing NKG2D CAR-T cells with piggyBac transposon vectors and K562 artificial antigen-presenting cells
por: Tay, Johan C.K., et al.
Publicado: (2021)

Effects of Reactive Nitrogen Scavengers on NK-Cell-Mediated Killing of K562 Cells
por: Zeng, Yili, et al.
Publicado: (2012)

X-ray-irradiated K562 feeder cells for expansion of functional CAR-T cells
por: Bui, Khac Cuong, et al.
Publicado: (2022)

SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity
por: Kim, Hanna, et al.
Publicado: (2022)

Inhibitory NKG2A(+) and absent activating NKG2C(+) NK cell responses are associated with the development of EBV(+) lymphomas
por: Vietzen, Hannes, et al.
Publicado: (2023)

NKG2A is a NK cell exhaustion checkpoint for HCV persistence
por: Zhang, Chao, et al.
Publicado: (2019)

High Metabolic Function and Resilience of NKG2A-Educated NK Cells
por: Highton, Andrew J., et al.
Publicado: (2020)

Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells
por: Riese, Peggy, et al.
Publicado: (2020)

Dissection of the NKG2C NK cell response against Puumala Orthohantavirus
por: Vietzen, Hannes, et al.
Publicado: (2021)

Publisher Correction: High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
por: Huisman, Brooke D., et al.
Publicado: (2023)

SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells
por: Hammer, Quirin, et al.
Publicado: (2022)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

GSK-3α Inhibition in Drug-Resistant CML Cells Promotes Susceptibility to NK Cell-Mediated Lysis in an NKG2D- and NKp30-Dependent Manner
por: Kim, Nayoung, et al.
Publicado: (2021)

NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development
por: Jelenčić, Vedrana, et al.
Publicado: (2018)

A Role for NKG2D in NK Cell–Mediated Resistance to Poxvirus Disease
por: Fang, Min, et al.
Publicado: (2008)

Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?
por: Della Chiesa, Mariella, et al.
Publicado: (2015)

NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML
por: Schlegel, Patrick, et al.
Publicado: (2015)

Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies
por: Melero, Ignacio, et al.
Publicado: (2023)

Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes
por: Costa-García, Marcel, et al.
Publicado: (2019)

CD56(dim)CD57(+)NKG2C(+) NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT
por: Cichocki, Frank, et al.
Publicado: (2015)

Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8(+) T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia
por: Pump, Wiebke C., et al.
Publicado: (2019)

NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses
por: Zingoni, Alessandra, et al.
Publicado: (2013)

NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs
por: Béziat, Vivien, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_s4ddg7ag1rqbl6ja9v7husvtit